These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
695 related articles for article (PubMed ID: 31534546)
1. Mitochondrial membrane anchored photosensitive nano-device for lipid hydroperoxides burst and inducing ferroptosis to surmount therapy-resistant cancer. Sang M; Luo R; Bai Y; Dou J; Zhang Z; Liu F; Feng F; Xu J; Liu W Theranostics; 2019; 9(21):6209-6223. PubMed ID: 31534546 [No Abstract] [Full Text] [Related]
2. BHQ-Cyanine-Based "Off-On" Long-Circulating Assembly as a Ferroptosis Amplifier for Cancer Treatment: A Lipid-Peroxidation Burst Device. Sang M; Luo R; Bai Y; Dou J; Zhang Z; Liu F; Feng F; Liu W ACS Appl Mater Interfaces; 2019 Nov; 11(46):42873-42884. PubMed ID: 31553151 [TBL] [Abstract][Full Text] [Related]
3. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib. Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851 [TBL] [Abstract][Full Text] [Related]
4. CD44-hyaluronan mediating endocytosis of iron-platinum alloy nanoparticles induces ferroptotic cell death in mesenchymal-state lung cancer cells with tyrosine kinase inhibitor resistance. Tsai T; Wu S; Lai Y; Wang H; Hou P; Huang Y; Chen HH; Su W Acta Biomater; 2024 Sep; 186():396-410. PubMed ID: 39067646 [TBL] [Abstract][Full Text] [Related]
5. Synergistic Amplification of Ferroptosis with Liposomal Oxidation Catalyst and Gpx4 Inhibitor for Enhanced Cancer Therapy. Yuan Y; Tian C; Wang Q; Qiu X; Wang Y; Jiang H; Hao J; He Y Adv Healthc Mater; 2023 Nov; 12(28):e2301292. PubMed ID: 37458333 [TBL] [Abstract][Full Text] [Related]
6. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator. He YJ; Liu XY; Xing L; Wan X; Chang X; Jiang HL Biomaterials; 2020 May; 241():119911. PubMed ID: 32143060 [TBL] [Abstract][Full Text] [Related]
7. Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy. Liu X; Zhu X; Qi X; Meng X; Xu K Int J Nanomedicine; 2021; 16():1037-1050. PubMed ID: 33603367 [TBL] [Abstract][Full Text] [Related]
8. Ferroptosis Promotes Photodynamic Therapy: Supramolecular Photosensitizer-Inducer Nanodrug for Enhanced Cancer Treatment. Zhu T; Shi L; Yu C; Dong Y; Qiu F; Shen L; Qian Q; Zhou G; Zhu X Theranostics; 2019; 9(11):3293-3307. PubMed ID: 31244955 [TBL] [Abstract][Full Text] [Related]
9. Dual GSH-exhausting sorafenib loaded manganese-silica nanodrugs for inducing the ferroptosis of hepatocellular carcinoma cells. Tang H; Chen D; Li C; Zheng C; Wu X; Zhang Y; Song Q; Fei W Int J Pharm; 2019 Dec; 572():118782. PubMed ID: 31678528 [TBL] [Abstract][Full Text] [Related]
10. An iron oxyhydroxide-based nanosystem sensitizes ferroptosis by a "Three-Pronged" strategy in breast cancer stem cells. Wu K; Zhang W; Chen H; Wu J; Wang X; Yang X; Liang XJ; Zhang J; Liu D Acta Biomater; 2023 Apr; 160():281-296. PubMed ID: 36822484 [TBL] [Abstract][Full Text] [Related]
11. Multifunctional "ball-rod" Janus nanoparticles boosting Fenton reaction for ferroptosis therapy of non-small cell lung cancer. Zhu G; Chi H; Liu M; Yin Y; Diao H; Liu Z; Guo Z; Xu W; Xu J; Cui C; Xing XJ; Ma K J Colloid Interface Sci; 2022 Sep; 621():12-23. PubMed ID: 35447518 [TBL] [Abstract][Full Text] [Related]
12. Biodegradable zwitterionic polymer-cloaked defective metal-organic frameworks for ferroptosis-inducing cancer therapy. Zhang M; Yao X; Xu J; Song J; Mai S; Zhu W; Zhang Y; Zhu L; Yang W Int J Pharm; 2024 Apr; 655():124032. PubMed ID: 38521374 [TBL] [Abstract][Full Text] [Related]
13. Mesoporous polydopamine carrying sorafenib and SPIO nanoparticles for MRI-guided ferroptosis cancer therapy. Guan Q; Guo R; Huang S; Zhang F; Liu J; Wang Z; Yang X; Shuai X; Cao Z J Control Release; 2020 Apr; 320():392-403. PubMed ID: 32004587 [TBL] [Abstract][Full Text] [Related]
14. Ferrous-Supply-Regeneration Nanoengineering for Cancer-Cell-Specific Ferroptosis in Combination with Imaging-Guided Photodynamic Therapy. Liu T; Liu W; Zhang M; Yu W; Gao F; Li C; Wang SB; Feng J; Zhang XZ ACS Nano; 2018 Dec; 12(12):12181-12192. PubMed ID: 30458111 [TBL] [Abstract][Full Text] [Related]
15. Biomimetic Cancer-Targeting Nanoplatform Boosting AIEgens-Based Photodynamic Therapy and Ferroptosis by Disrupting Redox-Homeostasis. Wan Y; Cao Y; Hu D; Lai Q; Liu Y; Chen Y; Wu M; Feng S ACS Biomater Sci Eng; 2024 Jun; 10(6):3813-3824. PubMed ID: 38779799 [TBL] [Abstract][Full Text] [Related]
16. Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance. Ren Y; Mao X; Xu H; Dang Q; Weng S; Zhang Y; Chen S; Liu S; Ba Y; Zhou Z; Han X; Liu Z; Zhang G Cell Mol Life Sci; 2023 Aug; 80(9):263. PubMed ID: 37598126 [TBL] [Abstract][Full Text] [Related]
17. Cashing in on ferroptosis against tumor cells: Usher in the next chapter. Valashedi MR; Najafi-Ghalehlou N; Nikoo A; Bamshad C; Tomita K; Kuwahara Y; Sato T; Roushandeh AM; Roudkenar MH Life Sci; 2021 Nov; 285():119958. PubMed ID: 34534562 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer. Lee J; You JH; Kim MS; Roh JL Redox Biol; 2020 Oct; 37():101697. PubMed ID: 32896720 [TBL] [Abstract][Full Text] [Related]
19. Multivalent Polypeptide and Tannic Acid Cooperatively Iron-Coordinated Nanohybrids for Synergistic Cancer Photothermal Ferroptosis Therapy. He M; Du C; Xia J; Zhang ZG; Dong CM Biomacromolecules; 2022 Jun; 23(6):2655-2666. PubMed ID: 35583462 [TBL] [Abstract][Full Text] [Related]